Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772730 · ClinicalTrials.gov registry record
Patient-Specific Precision Injury Signatures in Multiply Injured Orthopaedic Patients
A clinical trial, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- 320
- Enrollment target
NCT03772730: Completed study, sponsored by Major Extremity Trauma Research Consortium.
NCT03772730 is a clinical trial that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 320 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03772730 has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of precision methods that quantify injury and response to injury to predict how short-term clinical outcomes are affected by initial and staged orthopaedic interventions in multiply injured patients (MIPs) who sustain major orthopaedic trauma.
Primary Outcome
Number of occurrences of multiple organ dysfunction, nosocomial infection, wound complications, resource utilization and death as noted in medical record review.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2023-05-30 |
What the finished NCT03772730 record still lists
NCT03772730 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03772730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03772730 about?
NCT03772730 is a clinical study titled "Patient-Specific Precision Injury Signatures in Multiply Injured Orthopaedic Patients". The purpose of this study is to evaluate the use of precision methods that quantify injury and response to injury to predict how short-term clinical outcomes are affected by initial and staged orthopaedic interventions in multiply injured patients (MIPs) who sustain major orthopaedic trauma.
What is the current status of trial NCT03772730?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2019-03-20. Estimated completion is 2023-05-30.
Who is sponsoring clinical trial NCT03772730?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI